The effect of prostaglandin F2alpha administration on plasma steroid and LH levels in the luteal phase of the menstrual cycle.
D000328:Adult; D004967:Estrogens / Q000097:blood; D005260:Female; D006801:Humans; D008183:Luteal Phase / Q000187:drug effects; D007986:Luteinizing Hormone / Q000097:blood / Q000378:metabolism*; D008598:Menstruation; D009120:Muscle Cramp / Q000139:chemically induced; D009325:Nausea / Q000139:chemically induced; D011374:Progesterone / Q000378:metabolism*; D011460:Prostaglandins F / Q000009:adverse effects / Q000494:pharmacology*; D013997:Time Factors; D014599:Uterus / Q000187:drug effects
D004967:Estrogens; D011460:Prostaglandins F; D011374:Progesterone; D007986:Luteinizing Hormone